Dépôt numérique

DNA fragmentation factor 40 expression in T cells confers sensibility to tributyltin-induced apoptosis

Kulbay, Merve; Johnson, Bruno et Bernier, Jacques ORCID logoORCID: https://orcid.org/0000-0002-0594-5922 (2019). DNA fragmentation factor 40 expression in T cells confers sensibility to tributyltin-induced apoptosis Toxicology , vol. 426 , nº 152255. pp. 1-12. DOI: 10.1016/j.tox.2019.152255.

Ce document n'est pas hébergé sur EspaceINRS.


DNA fragmentation factor 40 (DFF40), an endonuclease, mediates the final and irreversible step of apoptosis by conducting oligonucleosomal DNA fragmentation. New emerging studies have proposed a role of DFF40 in genomic stability, besides its nuclease activity. Overexpression of DFF40 in tumoral cells increases their sensitivity to chemotherapeutic drugs. In this study, we sought to determine if DFF40 expression influences the toxicity of tributyltin (TBT), a well-known immunotoxic and apoptosis-inducing compound. The strategy used was to knockout DFF40 expression by CRISPR-cas9 method in Jurkat T cells and to determine the toxicity of TBT in DFF40 KO cells and DFF40 WT Jurkat cells. DFF40 KO Jurkat cells show an increase of cell viability following a 24-h TBT exposure (p < 0.05). There is a resistance to TBT-induced apoptosis determined by annexin V/PI am labeling (p < 0.05). Interestingly, the basal level of ROS rises in DFF40 KO Jurkat cells, but ROS production levels after TBT exposure remains at the same basal level. Other apoptosis or DNA damage makers (procaspase-3, caspase-6, and PARP cleavage) are significantly delayed and decreased. DFF40 deficient cells do not present histone H2AX phosphorylation, whereas wild-type cells present a phosphorylation following a 6-h exposure to TBT (p < 0.001). The re-expression of DFF40 in DFF40 KO cells restores the cytotoxic effects of TBT. Overall, these data suggest a role of DFF40 in cells sensitivity to TBT and possibly in DNA stability.

Type de document: Article
Mots-clés libres: Apoptosis; DFF40; Tributyltin; CRISPR-cas9; Genomic stability
Centre: Centre INRS-Institut Armand Frappier
Date de dépôt: 27 janv. 2020 16:49
Dernière modification: 14 févr. 2022 20:15
URI: https://espace.inrs.ca/id/eprint/8582

Gestion Actions (Identification requise)

Modifier la notice Modifier la notice